High-Flow Nasal Cannula Market Size, Share & Analysis By 2027

High-Flow Nasal Cannula Market to 2027 - Global Analysis and Forecasts By Component (Air Oxygen Blender, Nasal Cannula, Heated Inspiratory Circuit, and Active Humidifier); Application (Bronchiectasis, Acute Respiratory Failure, Acute Heart Failure, and Chronic Obstructive Pulmonary Disease); End User (Ambulatory Care Centers, Hospitals and Long-Term Care Centers) and Geography

Publication Month : Dec 2019

  • Report Code : TIPMD00002292
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 152
Inquire Before Buy

PRICING

$4550

$2730

The High Flow Nasal Cannula market was valued at US$ 4,390.74 million in 2018 and it is projected to reach US$ 11,198.78 million by 2027; it is expected to grow at a CAGR of 11.1% from 2019 to 2027.

 

High flow nasal cannula (HFNC) is an oxygen supply system that is capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 60 liters per minute. HFNC has been gaining attention as alternative respiratory support for critically ill patients. HFNC is used for the treatment of respiratory conditions such as asthma and COPD, however useful for treating hypercapnic respiratory failure and mild to moderate hypoxemic respiratory failure can be done using high flow nasal cannula. The growth of the High Flow Nasal Cannula market is attributed to the rising incidences if asthma and COPD across the globe and rising geriatric population. However, the side effects associated with the use of high-flow nasal cannula is expected to hamper the growth of the market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

High-Flow Nasal Cannula Market: Strategic Insights

high-flow-nasal-cannulamarket
Market Size Value inUS$ 4,390.74 Million in 2018
Market Size Value byUS$ 11,198.78 Million by 2027
Growth rateCAGR of 11.1% from 2019-2027
Forecast Period2019-2027
Base Year2019
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The High Flow Nasal Cannula market is expected to witness substantial growth post-pandemic. The High Flow Nasal Cannula  market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for High Flow Nasal Cannula Market


  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Growing Applications of High Flow Nasal Cannula in Healthcare to Drive High Flow Nasal Cannula Market Growth

The number of cases of asthma and COPD has been growing all over the world at a substantial rate. In recent years, the number of smokers and the levels of air pollution in developed, as well as developing countries, is increasing across the globe. Asthma is a medical condition where the airways swell and narrow and also produces mucus. This further leads to wheezing, coughing, and recurrent attacks of breathlessness, which differ in severity and frequency from person to person. 

According to the World Health Organization estimates, there are approximately 235 million people suffering from asthma around the world. Moreover, the Centers for Disease Control and Prevention (CDC) reported, approximately19 million adults in the United States (18 years of age or above) are currently suffering from asthma, which accounts for almost 7.7% of the total adult population. Whereas, about 6.2 million patients below 18 years of age have asthma, which accounts for 8.4% of the total children population. Also, according to the WHO estimates published during December 2016, there were around 383,000 deaths due to asthma in 2015.

Similarly, the number of patients suffering from COPD across the globe is growing. Chronic obstructive pulmonary disease (COPD) is a long term lung disease that causes shortness of breath, chest tightness, chronic cough, respiratory infections, wheezing, and others. According to the WHO Global Burden of Disease Study report, in 2016, globally, around 251 million people were suffering from COPD. Furthermore, the report also mentioned that approximately 3.17 million deaths across the globe were caused due to COPD in the year 2015, which accounts for almost 5% of all deaths in 2015. In recent years, the prevalence of COPD in developed nations is also increasing. For instance, COPD is the third leading cause of death in the United States, and over 11 million patients in the US have been diagnosed with COPD. Thus, the rising prevalence of respiratory conditions such as asthma and COPD and increasing applications of high flow nasal cannula in treating such diseases is anticipated to fuel the growth of the high flow nasal cannula market across the globe at an exponential rate.

COPD and asthma are senescence condition, which leads to gradual complications. Asthma in older adults is a critical condition that often goes unnoticed, as per the Asthma and Allergy Foundation of America (AAFA). According to the Office of Disease Prevention and Health Promotion (ODPHP), approximately 23 million people in the U.S. have some form of asthma, most of which include the older population. Older people with asthma often need high doses of medication, in spite of mild asthma attacks. Hence, they are more likely to suffer from respiratory failure much faster as compared to the younger population. Also, COPD can appear at any age. However, it is more prevalent in the older population and can be fatal. The aging population is growing exponentially worldwide. 

According to a report of the United Nations (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach 425 million by 2050. The number of the elderly population is expected to grow significantly in Africa, followed by North America, Latin America & the Caribbean, and the Asia Pacific region.

The elderly people are more likely to have COPD and asthma than younger people, and the effect of the disease on quality of life is particularly deep in this population. With increase in the number of geriatric population, the prevalence of the COPD and asthma will increase significantly. Also, the number of hospital admissions and number of surgeries will increase. Thus, the demand for high flow nasal cannula market is expected to increase in the forecast period.


Component-Based Insights

In terms of component, the High Flow Nasal Cannula market is segmented into air oxygen blender, nasal cannula, heated inspiratory circuit, active humidifier. Active humidifier segment held the largest share of the market. Moreover, this segment is also expected to register the highest CAGR of 11.7% in the market during the forecast period.

High Flow Nasal Cannula Market, by Component – 2018 and 2027



  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Application-Based Insights

Based on application, the High Flow Nasal Cannula market is segmented into bronchiectasis, acute respiratory failure, acute heart failure, and chronic obstructive pulmonary disease. In 2018, the chronic obstructive pulmonary disease (COPD) accounted for the largest market share in the global highflow nasal cannula market by application.

End User-Based Insights

In terms of end user, the High Flow Nasal Cannula market is segmented into ambulatory care centers, hospitals, long term care centers. In 2018, the hospitals segment held the largest share of the market. Moreover, the segment is also expected to register the highest CAGR of 11.4% in the market during the forecast period.

The High Flow Nasal Cannula market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

High Flow Nasal Cannula Market – by Component

  • Air Oxygen Blender
  • Nasal Cannula
  • Heated Inspiratory Circuit
  • Active Humidifier

High Flow Nasal Cannula Market – by Application

  • Bronchiectasis
  • Acute Respiratory Failure
  • Acute Heart Failure
  • Chronic Obstructive Pulmonary Disease (COPD)

High Flow Nasal Cannula Market – by End User

  • Hospitals
  • Ambulatory Care Centers
  • Long-Term Care Centers

High Flow Nasal Cannula Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Fisher & Paykel Healthcare Limited.
  • ResMed
  • Great Group Medical Co., Ltd.
  • Salter Labs
  • TNI Medical Ag
  • Mek-Ics Co., Ltd.
  • Flexicare Medical Limited
  • Vapotherm
  • Teleflex Incorporated
  • Hamilton Medical
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Component ; Application ; End User and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

Frequently Asked Questions


What are high flow nasal cannula?

High flow nasal cannula (HFNC) is an oxygen supply system that is capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 60 liters per minute. HFNC has been gaining attention as an alternative respiratory support for critically ill patients. HFNC is used for the treatment of respiratory conditions such as asthma and COPD, however useful for treating hypercapnic respiratory failure and mild to moderate hypoxemic respiratory failure can be done using high flow nasal cannula.

What are the driving factors for the dPCR and qPCR industry across the globe?

Driving factors such as growing incidences of asthma and COPD across the globe and growing geriatric population are expected to boost the market growth over the years. Moreover, increasing acceptance of home oxygen therapy is likely to have a positive impact on the growth of the market in the coming years.

What is the average cost of dPCR and qPCR?

A high flow nasal cannula can cost between US$ 400 to USD$ 700 and the cost can vary depending on the material, technology, and location of manufacturer.

The List of Companies

  1. Great Group Medical Co., Ltd.
  2. Salter Labs
  3. TNI Medical Ag
  4. Mek-Ics Co., Ltd
  5. Flexicare Medical Limited
  6. Vapotherm
  7. Teleflex Incorporated
  8. Hamilton Medical
  9. Fisher & Paykel Healthcare Limited
  10. ResMed

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to High-Flow Nasal Cannula Market